Development of attenuated Salmonella strains that express heterologous antigens.
Bowe
Frances
F
Centre for Molecular Microbiology and Immunology, Department of Biological Sciences, Imperial College, London, United Kingdom.
Pickard
Derek J
DJ
Anderson
Richard J
RJ
Londoño-Arcila
Patricia
P
Dougan
Gordon
G
D000284:Administration, Oral; D000941:Antigens / Q000235:genetics*; D017100:Bacteriophage P22 / Q000235:genetics; D002876:Chromosomes, Bacterial / Q000235:genetics; D004274:DNA, Recombinant / Q000235:genetics; D018274:Electroporation; D005818:Genetic Engineering; D005822:Genetic Vectors; D008070:Lipopolysaccharides / Q000737:chemistry / Q000276:immunology; D010957:Plasmids / Q000235:genetics; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D012475:Salmonella / Q000235:genetics*; D014161:Transduction, Genetic; D014170:Transformation, Genetic; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000235:genetics*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000235:genetics
D000941:Antigens; D004274:DNA, Recombinant; D008070:Lipopolysaccharides; D011994:Recombinant Proteins; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic